Categories

Vyaire Medical Issues Voluntary Correction for Certain bellavista™ Ventilators in Specific Software Configurations

In December 2021, imtmedical ag, a subsidiary of Vyaire Medical, initiated a voluntary field correction for certain bellavista™ ventilators. With specific software version and configuration combinations, the ventilators can cease ventilation and generate a technical failure alarm 305. There is a pot

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vyaire-medical-issues-voluntary-correction-certain-bellavistatm-ventilators-specific-software

 
Categories

Junp LLC Issues Voluntary Nationwide Recall of MegMan Performance Booster Capsules Due to the Presence of Tadalafil

Brooklyn, NY Junp LLC is voluntarily recalling Lot number 2010291, Exp Date: 01/07/2024 of MegMan Performance Booster capsules, packaged in 10-count blisters packaged in a carton to the consumer level. Junp LLC was notified by Amazon that laboratory analysis has found the product to be tainted wit

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/junp-llc-issues-voluntary-nationwide-recall-megman-performance-booster-capsules-due-presence

 
Categories

SD BIOSENSOR, Issues Notification of Voluntary Recall of ‘STANDARD Q COVID-19 Ag Home Test’

Biosensor, Inc., a global in-vitro diagnostics company, is voluntarily recalling its STANDARD Q COVID-19 Ag Home Test in the United States, due to confirmed reports that the test kits were illegally imported into the United States. The STANDARD Q COVID-19 Ag Home Test is not authorized, cleared or a

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sd-biosensor-issues-notification-voluntary-recall-standard-q-covid-19-ag-home-test

 
Categories

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema3 de febrero de 2020. La Comisión Nacional de Vacunación y Epidemiología (CNVE) aprobó que a partir de hoy se reduzca a cinco

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2267-tercera-dosis-de-vacuna-contra-covid-19-puede-aplicarse-a-cinco-meses-de-haber-completado-esquema